Who we are

Directors

• 

  Christian Hill

  CEO

  

  Christian Hill

  CEO

  Christian is a life sciences patient access professional with over 20 years of experience in the International Biotech, Pharmaceutical and MedTech industry. He has been involved in over 60 HTAs and pricing procedures globally and has built up a strong network of key influencers including regional and national agencies. Prior to co-founding MAP in 2012, he led market access and public affairs teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

  Christian is a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland; he is also a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs).
  

• 

  Dawn Hill

  COO

  

  Dawn Hill

  COO

  MAP was founded by Dawn who has worked in national and local government departments ranging from Business, Agriculture, Education and Finance for over twenty years.

  This experience was primarily focused on business and administration processes and, importantly for MAP BioPharma, the simplification and efficiency of these processes.

  Dawn therefore founded MAP BioPharma Limited and combines business and administration expertise with contacts in the Health Service, Biotech and Pharmaceutical sectors to deliver valuable resources to support Market Access for medicines in the UK and Ireland.

• 

  Mark Harries

  CCO

  

  Mark Harries

  CCO

  Mark has in-depth understanding and experience of Health Technology Appraisals in the UK, Europe and US, optimising submissions to achieve successful outcomes for both primary care and specialist products including orphan drugs. Mark joined MAP in 2014, prior to this he spent 6 years at WG Consulting as Managing Director, driving one of the highest levels of performance within the market access industry. Previously, Mark was a pharmacist in the NHS for 14 years, with his last position being Lead Directorate Pharmacist of Paediatric and Adolescent Medicine at University College London Hospitals NHS Trust.

  Mark has worked on a diverse range of Market Access consultancy programmes in the EU and US and offers an in-depth understanding of the issues and opportunities for a product at all stages in its lifecycle with the ability to provide the right solutions for clients, which will resonate with a variety of stakeholders at a clinician or payer level.

• 

  Andy Swarbrick

  Chairman

  

  Andy Swarbrick

  Chairman

  Andy brings with him 30 years of experience as a partner at Deloitte in Cambridge. He has a strong commercial background and an array of skills in financial management, strategic planning, HR and marketing both from an advisory perspective and from a career spent in various management roles within Deloitte. Pragmatic but with great attention to detail, an enquiring mind and a “can do” approach, he has much experience of building relationships and alliances, strong political skills and very significant experience in the owner manager/entrepreneurial and charity sectors. His various roles within the Deloitte Cambridge office ranged from Staff Partner, to Head of Business Development, to Head of Audit and to Senior Partner. He was for many years a Trustee of the Deloitte staff pension fund.

  His other current roles include Chairman of an executive search business and Non Exec Director of a regional law firm. For over 30 years he has been a trustee of an employee trust that owns a laboratory supply business. He also works with a number of charitable organisations, being a Trustee/Director of the Cambridge Arts Theatre, the Cambridge Union and until very recently the Arthur Rank Hospice Charity. He is also Chairman of the Cambridge Music Festival and a member of the Advisory Council of the London Philharmonic Orchestra.

Operations

• 

  Laura Carter

  Office Manager/PA to CEO and COO

  

  Laura Carter

  Office Manager/PA to CEO and COO

  Laura brings to MAP 16 years administration experience and has been in the Pharmaceutical industry for 4 years. Prior to that she was in the Ministry of Defence for 10 years in a variety of roles including information technology. She holds a National Vocational Qualification in Business Administration.
  

• 

  Lynne Stoten

  Financial Controller

  

  Lynne Stoten

  Financial Controller

  Lynne is a member of ACCA and holds a BA Hons Degree in Business Economics from Anglian Ruskin University. Lynne has 20 years’ experience working in the finance departments of technology companies which began their lives as start-up businesses, established to develop new technology born from Cambridge University. Lynne has established financial systems and processes which have ensured continuity of the finance function through their transitional program towards to a successful exit strategy and beyond. Lynne joined MAP in June 2017, assisting Dawn Hill, MAP’s Chief Financial Officer, to grow the strong and efficient finance functions within MAP.

• 

  Mark Gale-Jones

  Personnel Manager

  

  Mark Gale-Jones

  Personnel Manager

  Mark is the Personnel Manager for MAP BioPharma working with the Senior Management team on the overall People Strategy for the company. Mark comes from a training and recruitment background, completing his Certificate in Recruitment Practice and has worked with some large multi-national companies in the engineering and medical devices industry. Mark has extensive experience in conducting Training Needs Analysis for individuals and on a corporate level. Mark has extensive knowledge of the recruitment process, interview techniques and assessment practices and has worked with and for Apprenticeship Training Providers so is well placed to lead on MAP’s Apprenticeship recruitment and selection process.

  Mark has a BA (Hons) in International Relations and Politics from De Montfort University, Leicester, and part of his early career worked for one of the publishing houses for the Commonwealth Secretariat building relationships with key overseas influencers within the 3rd world market.

• 

  Amanda Wright

  Finance and Operations Assistant

  

  Amanda Wright

  Finance and Operations Assistant

  Amanda is qualified up to level 3 of the AAT qualification, also holding NVQs in Business Administration levels 2 and 3, and Information Technology level 2. She has over 20 years' experience working within an accounting function, holding various positions. Ten years of this were spent in the bursary of a Cambridge college, and she also has experience working within a financial and insurance services company. Most recently Amanda worked for a Japanese pharmaceutical company within their finance department.

MAP Online Team

• 

  Stephen Norton PhD

  MAP Online Manager

  

  Stephen Norton PhD

  MAP Online Manager

  Stephen joined MAP from Anglia Ruskin University where he advised researchers in winning funding. This followed time managing schemes for the BBSRC, the major national funder of biological research. Stephen completed a PhD in Biophysics of an Amyloid Protein at the University of Warwick, where he also gained a Master’s degree in Mathematical Biology and Biophysical Chemistry. His Bachelor’s degree is from Lancaster University in Biomedicine and Medical Statistics. Stephen’s interests have always been in health and biomedicine, and he leads the MAP Online service, helping bring new products to market.
  

• 

  Sarah Borley

  MAP Online Support

  

  Sarah Borley

  MAP Online Support

  Sarah has joined the MAP Online as an Associate Consultant bringing her experience of administration and customer care. Sarah studied childcare at Cambridge Regional College and had worked in childcare for 6 years, before changing her career direction to Receptionist. Following on from being the Reception Administrator within MAP, she joins us in the MAP Online team to manage, develop and maintain client relationships.

• 

  Douglas Hall

  Associate Consultant MAP Online

  

  Douglas Hall

  Associate Consultant MAP Online

  Doug did his PhD in Medical Research at the University of Cambridge in the lab of an academic clinician working with Cancer Research UK, following an undergraduate masters in Biochemistry at the University of Oxford. Doug’s PhD project looked at the molecular biology of high-grade serous ovarian cancer, and the implications of this for treatment and disease relapse. His interest in translating fundamental biochemistry into insights and proposals for improving outcomes for clinical practice made a market access role with MAP a natural career move.

• 

  William Cole

  Sales and Business Development Executive

  

  William Cole

  Sales and Business Development Executive

  William is a senior sales and marketing professional, with a career developed with some of the best companies in the world, including Roche, Lloyds Bank, Standard Life and General Electric. A member of the Chartered Institute of Marketing and an experienced healthcare market access specialist, William has experience launching high cost drugs, orphan drugs and medical devices along with B2B success selling direct to the NHS a variety of products including EDMS, and consultancy services. Prior to Joining MAP BioPharma, William was leading the development and implementation of innovative market access initiatives for Roche Products Ltd, for their flagship breast cancer brands in the UK. William is also a former international athlete and Commonwealth Games gold medallist.

• 

  Oliver Hulisz

  Web Design and Development

  

  Oliver Hulisz

  Web Design and Development

  Oliver Hulisz is head of web design and development at MAP. He has developed more than 50 websites for a range of companies and specialises in WordPress.

  Oliver provides day to day maintenance and updates for the continuously improving and evolving MAP websites as well as ensuring that our technical approach to delivering maximum value to our online clients is always fresh and making the most of the latest available developments. His company 72dpi netzbüro is based in Essen, Germany.

Market Access Team

• 

  Jade Marshall

  Director Health Economics and Outcomes Research

  

  Jade Marshall

  Director Health Economics and Outcomes Research

  Jade has written and supported more than 20 health technology appraisals (HTAs) to HTA agencies in the UK (NICE, SMC, AWMSG), Sweden (TLV), Ireland (NCPE) and Canada (CADTH, INESSS). She specialises in providing strategic advice for health technology assessments of rare diseases and is responsible for constructing value stories, conducting systemic literature reviews and the design and development of health economics models such as cost-utility, cost-effectiveness and budget impact models.

  Jade has a Masters in Economic Evaluation in Healthcare from City University London. She has a First Class Masters degree in Engineering Mathematics from the University of Bristol where her thesis focussed on dynamical infectious disease modelling. Prior to this, Jade had a position within a NHS public health team, supporting training of healthcare professionals.

• 

  Nick Bruce

  Director Market Access

  

  Nick Bruce

  Director Market Access

  Nick worked as an NHS economist and commissioner at Health Authorities in South West London, during which time he held an honorary lectureship at St George’s Hospital Medical School, London. After leaving the NHS, Nick worked for a health economics consultancy before joining Pfizer in 1998 to set up its market access team. In a twenty year pharmaceutical industry career at Pfizer and Amgen, he held UK Leadership Team roles responsible for market access, health policy, government affairs and media communications. Nick was an ABPI representative on the Scottish Medicines Consortium appraisal committee, and a former member of the ABPI Board of Management.

• 

  Lizzy Balman PhD

  Senior Scientific Consultant

  

  Lizzy Balman PhD

  Senior Scientific Consultant

  Lizzy has over 9 years experience in market access consulting for the pharmaceutical industry, and has in-depth experience of health technology appraisals in both the UK and Europe, where she inputs into the strategy, clinical writing, systematic literature reviews, evidence interpretation and alignment of the clinical evidence and health economic modelling. She also has a critical understanding of appraisal processes and timelines and has managed numerous successful submissions through to final recommendations, often within tight deadlines. She has broad experience developing clinical and payer communications, as well as research interviews and advisory panels. Lizzy has worked extensively in rare diseases, has a keen interest in genetic disorders, and has worked across diverse therapeutic areas including oncology, haematology, respiratory, ophthalmology and neurology (multiple sclerosis).

  In her earlier academic career Lizzy graduated from the University Glasgow with a degree in Genetics followed by a Masters of Research in Biomedical Sciences. She then worked in vaccine research at the Edward Jenner Institute where she specialised in researching the basis of dendritic cell activation, and went on to complete a PhD in this area.

• 

  John Nikolettos PhD

  Consultant Market Access

  

  John Nikolettos PhD

  Consultant Market Access

  John graduated from the University of Reading with a Masters degree in Pharmacy (MPharm). During his academic studies he interned at the Biomedical Research Foundation of the Academy of Athens (BRFAA) obtaining additional scientific and research experience. John then went on to pursue a PhD in Pharmaceutics, at the University of Bath where the focus of his doctorate was on the development of dissolution studies for intra-articular formulations. During his time at the University of Reading, John was elected president of the Greek-Cypriot Society and at the University of Bath he was voted the Graduate Academic Representative for the Pharmacy & Pharmacology department. John joined MAP as an Associate Consultant in 2017 and has been involved in a wide range of projects. His role includes clinical writing, pricing and reimbursement strategy development and project management.
  

• 

  Alex Tothill PhD

  Associate Consultant Market Access and MAP Online

  

  Alex Tothill PhD

  Associate Consultant Market Access and MAP Online

  Alexander has pursued and successfully completed a PhD in Diagnostics and Biomedical Engineering focussing on low cost 3D-printed microfluidic medical devices and whole blood glucose and cholesterol assays. He has presented sections of his doctoral work at leading biosensor conferences in addition to scientific journal publications. Prior to his doctoral research, Alexander interned as a scientific researcher at Cranfield University in the field of molecularly imprinted polymers for use in drug detection. Alexander also has a Masters degree in Pharmacy (MPharm) from the University of Bradford. During his pharmacy training, he gained valuable clinical experience in both hospital and community settings. Alexander joined MAP in November 2017 as an Associate Consultant.

• 

  Catherine Mak

  Associate Consultant Health Economics and Outcomes Research

  

  Catherine Mak

  Associate Consultant Health Economics and Outcomes Research

  Catherine graduated with an MPharm degree from University College London. Following successful completion of her qualifying year, she registered as a pharmacist and started studying for an MSc in Economic Evaluation in Healthcare at City, University of London. During her pharmacy training, Catherine gained clinical experience in both primary and secondary care in the UK, in the not-for-profit health organisation HealthServe and the healthcare system in Singapore. She has undertaken neuroscience research at the UCL Institute of Neurology and research in nanotechnology drug delivery at the Melbourne ARC Centre of Excellence in Convergent Bio-Nano Science and Technology. Before joining MAP as an Associate Consultant in October 2017, Catherine worked on a variety of health economic models and enjoys drawing on her experience in pharmacy, health economics and research to help communicate economic and clinical outcomes effectively.

• 

  Maxim Souter

  Associate Consultant Health Economics and Outcomes Research

  

  Maxim Souter

  Associate Consultant Health Economics and Outcomes Research

  Maxim works in the health economics team where he conducts systematic literature reviews, develops economic models and manages health technology assessment submissions to regulatory bodies. This includes both budget impact and cost-effectiveness analyses in a wide range of disease areas. Maxim is a qualified facilitator for the National Institute for Health and Care Excellence (NICE) MedTech Early Technical Assessment (META) Tool. He acts as the MAP lead for META projects as well as contributing to a broader range of market access projects. Maxim graduated with a Masters in Health Economics from the University of East Anglia, specialising in decision analytic modelling for cardiovascular diseases.

• 

  Muksitur Rahman

  Associate Consultant Health Economics and Outcomes Research and MAP Online

  

  Muksitur Rahman

  Associate Consultant Health Economics and Outcomes Research and MAP Online

  Muksit recently graduated with a Masters in Health Economics from City, University of London. He interned at NHS Improvement for his dissertation within the pricing and costing department, where he compared the different costing models used by NHS trusts. Muksit also has a Masters degree in Pharmacy (MPharm) from the Leicester School of Pharmacy. He has over five years experience as a pharmacist in the community setting. Muksit joined MAP in April 2018 as an associate consultant.

• 

  Nermina Ferizović

  Associate Consultant Health Economics and Outcomes Research

  

  Nermina Ferizović

  Associate Consultant Health Economics and Outcomes Research

  As a Health Economist at MAP, Nermina develops budget impact and cost-effectiveness analysis models in a wide range of disease areas including infectious disease. In addition, this includes the generation of data from real-world evidence sources such as claims and medical data. Further, Nermina authors health technology assessment submissions for regulatory bodies and is involved in the project management and the development of market access strategies for pharmaceutical and biotechnology companies. Nermina has a special interest in the use of real-world evidence in health economics and outcomes research with two years previous experience in real-world evidence. Nermina holds an MSc in Health Economics and Health Policy from The University of Birmingham with her dissertation project having focussed on epidemiological modelling in health economics.
  

• 

  Brian Gavin

  Market Access & Government Affairs Consultant Republic of Ireland

  

  Brian Gavin

  Market Access & Government Affairs Consultant Republic of Ireland

  Brian Gavin has over twenty-five years’ experience in the healthcare sector across a range of senior management positions both in Ireland and internationally. Most of his industry experience was with GlaxoSmithKline where he held a number of senior management positions including Global Commercial Strategy Manager for Seretide, Commercial Director for GSK Ireland and subsequently Corporate Affairs Director with the company.

  Since 2009, Brian has provided consultancy services to a broad range of pharmaceutical companies including Almirall, Janssen, Biogen IDEC, Reckitt Benckiser, Mundipharma, Takeda, Bausch & Lomb, Bayer and InterMune.

  He has extensive experience in the submission of HTA’s to the National Centre for Pharmacoeconomics and has completed desk and field based research across a broad range of therapy areas. Developed over a number of years Brian has a comprehensive network of contacts across a broad spectrum of stakeholders in the Irish healthcare environment.

• 

  Mark Edwards

  Medical and R&D Advisor

  

  Mark Edwards

  Medical and R&D Advisor

  Mark Edwards [BSc (hons) MB BS FRCA FSB] is a medically-qualified (anaesthesia and critical care) and GMC-registered drug developer with over 20 years’ pharma R&D experience. Formerly, he was a Global Clinical R&D Director and then Director of Science and Medical Public Affairs at Pfizer. He has worked at all phases of clinical development across a wide variety of therapeutic areas.

  His experience has also included the establishment of major R&D projects at the interfaces between academia, the NHS and the biopharma industry e.g. having helped lead the establishment of 1) MRC/industry pre-competitive consortia in COPD and RA and 2) the UK Government’s Translational Research Partnership Programme.

  Mark is also R&D Director of the Ethical Medicines Industry Group, R&D Director of OBN, Pharmaceutical Business Adviser for South East Health Technologies Alliance, Non-Executive Director of MRC Technology and a member of Manchester University’s Drug Discovery and Life Sciences Advisory Boards. He also supports a range of public and charitable sector organisations in the UK.

Policy and Public Affairs Team

• 

  Tessa Hughes

  Associate Director - Head of Policy and Public Affairs

  

  Tessa Hughes

  Associate Director - Head of Policy and Public Affairs

  Tessa has over ten years’ experience in policy and public affairs. She has worked for charities and spent seven years within two award-winning healthcare communications consultancies working across a range of areas, including corporate communications, cancer, cardiovascular disease and diabetes. She has a detailed understanding of the UK health policy environment, including access to medicines issues, levers and incentives and new care models. She has managed a range of successful campaigns, including securing better access to medicines and support for improved cancer awareness.

• 

  Sarah Walker

  Consultant Policy and Public Affairs

  

  Sarah Walker

  Consultant Policy and Public Affairs

  Sarah has over twenty-five years’ experience working in policy and public affairs roles. She worked for a Member of Parliament and for a political publication, before joining a leading public affairs consultancy with a specialist unit dedicated to the health sector. She has worked on both corporate and disease specific public affairs programmes for clients including Merck Sharp & Dohme, Sandoz and the London and Thames Valley Pharmaceutical Group which included some of the UK’s largest pharmaceutical companies. Outside healthcare she has experience of developing strategic public affairs programmes for leading companies including Marks & Spencer and Tate & Lyle. Since joining MAP BioPharma her work has included a significant number of projects in the rare disease arena and she has a detailed knowledge of the key stakeholders in this sector. Sarah has a strong network of contacts and a detailed understanding of the workings of Parliament and the development of policy.

Marketing

• 

  Leanne Walsh

  Head of Marketing

  

  Leanne Walsh

  Head of Marketing

  Leanne has in excess of 15 years experience with global biotech and pharmaceutical companies, in a variety of increasingly senior roles that have focused on marketing and launch excellence. These have included several successful high profile product launches, brand lifecycle management and customer segmentation across multiple disease areas. Most recently she has worked as an independent contractor in global / EU leadership roles providing a best in class rare disease product launch. Leanne joins MAP as Head of Marketing.

Legal Team

• 

  Paul Ranson

  Legal Consultant

  

  Paul Ranson

  Legal Consultant

  Paul Ranson is a lawyer with some 30 years pharmaceutical industry experience. He was formerly an in-house lawyer for Smith Kline, Merck Sharp & Dohme and Eli Lilly before going into private practice where he was a partner of two large international law firms Fasken Martineau and Pinsent Masons. His particular field of expertise is in the EU regulatory and commercial laws affecting pharmaceutical and device companies. This includes some 50 major licensing and product acquisition/divestment transactions. He has been recommended in the main legal directories for life sciences lawyers (Chambers, Legal 500 and others) for some 15 years.

  Beyond legal practice, Paul is a non-executive director of two pharmaceutical companies. He lectures widely and has written or co-written some 10 books or reports on legal issues including collaborations, product liability, outsourcing, pricing and reimbursement and manufacturing and clinical research. He is also the main author of the legal section of the Manchester University MSc on Pharmaceutical Licensing. He is the legal advisor to the Ethical Medicines Industry Group, the trade association for mid-sized pharma companies. He spent 5 years on an IEC.

• 

  Angelika Gornikowska

  Legal Counsel

  

  Angelika Gornikowska

  Legal Counsel

  Angelika began her legal journey in Poland where she obtained a Masters’ Degree in Law and gained experience in international corporate and commercial law. Having developed an interest in the common law system, Angelika has recently graduated from BPP University with a Distinction in Graduate Diploma in Law. She actively supports MAP clients and members by conducting legal research, as well as leading the development of MAP Online Legal section with insights in the areas of marketing authorisation, intellectual property, data protection, Brexit and EU competition law. She also has expertise in the ABPI Code of Practice and regularly participates in conferences and meeting groups where she helps realise MAP’s vision to accelerate patient access to medicines, medical devices and diagnostics.

Philanthropy

• 

  Philanthropy

  

  Philanthropy

  We support Help for Hope which promotes equal opportunities for all children.

  It was founded by a group of like minded life science professionals, one of whom recently helped us on a personal level. We were touched by their ethical approach whereby all admin costs for the charity are paid for by their own businesses.

  This means that 100% of our donations directly support specific projects to help underpriviledged children, providing them with opportunities to become agents of a better future. Link: help-for-hope.org